The experiments showed that TGF-β-induced Smad3 activation led to an increase in VISTA expression in various cell types including resting CD4-positive Jurkat T cells, primary human AML blasts derived from myeloid cell precursors, primary human embryonic cells, Wilms tumor cells, chronic AML cells and HaCaT keratinocytes. This evidence concerns the gene CD4 and Wilms tumor.